BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 97 filers reported holding BELLICUM PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 2.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,333,000 | +22.0% | 2,583,840 | -0.7% | 0.00% | +50.0% |
| Q3 2019 | $2,731,000 | +2.7% | 2,601,064 | +66.2% | 0.00% | 0.0% |
| Q2 2019 | $2,660,000 | -20.0% | 1,564,959 | +58.7% | 0.00% | -33.3% |
| Q1 2019 | $3,323,000 | +151.6% | 985,959 | +118.0% | 0.00% | +200.0% |
| Q4 2018 | $1,321,000 | +91.4% | 452,233 | +329.9% | 0.00% | – |
| Q2 2018 | $690,000 | 0.0% | 105,200 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $690,000 | -75.4% | 105,200 | -53.7% | 0.00% | -75.0% |
| Q1 2017 | $2,804,000 | +148.4% | 227,200 | +174.1% | 0.00% | +100.0% |
| Q4 2016 | $1,129,000 | – | 82,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,051,441 | $3,070,000 | 0.79% |
| X-Square Capital, LLC | 109,832 | $321,000 | 0.25% |
| KNOTT DAVID M | 111,427 | $325,000 | 0.15% |
| ARK Investment Management | 1,033,491 | $3,018,000 | 0.12% |
| Baker Brothers Advisors | 2,677,818 | $7,819,000 | 0.06% |
| HARVEY CAPITAL MANAGEMENT INC | 31,200 | $91,000 | 0.05% |
| DAFNA Capital Management LLC | 30,000 | $88,000 | 0.04% |
| WASATCH ADVISORS LP | 953,368 | $2,784,000 | 0.04% |
| FRANKLIN STREET ADVISORS INC /NC | 51,415 | $150,000 | 0.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,000,000 | $2,920,000 | 0.02% |